EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

ROLE OF SILDENAFIL IN MANAGEMENT OF POST-OPERATIVE PULMONARY HYPERTENSION IN CHILDREN.

Umair Younus*, Iftikhar Ahmed, William M.Novick, Syed Aqeel Hussain, Rashad Siddiqi, Nadeem Sadiq, Frank L. Molloy and Thomas G. Di Sessa

ABSTRACT

Objective: To evaluate the effectiveness of oral sildenafil on post-operative pulmonary hypertension in children following surgery for congenital heart disease. Study design: Retrospective Analytical study Patients and Methods: Fifty four consecutive patients between 2005 and 2013 with congenital heart defects (ventricular septal defects and patent ductus arteriosus) with systemic or supra systemic pulmonary artery pressures post operatively were included in the study. In all these patients sildenafil was given post operatively and the Ratio of pulmonary artery pressures to systemic pressures was recorded and presented as a percentage. These pressures were recorded at 0, 1, 6, 12 and at 24 hours intervals. After discharge pulmonary artery pressures were calculated by transthoracic echocardiography at 3 and 6 months and at one year. Results: The age of patients ranged from 1 to 28 years (mean of 7.2 ± 6.1 years) and 53.7%(n=29) were male. The mean PA pressures were 90.52±17.19 percent of aortic pressures pre-operatively, which dropped to 57.94 (+/- 12.60) percent of aortic pressures after 24 hours (p<0.001) with sildenafil therapy. A further decrease in pulmonary artery pressures was seen at 3 months (42.29 +/- 13.59) percent of aortic pressures, at 6 months (34.23 +/- 14.60) percent of aortic pressures. After 1 year the PA pressures were 31.17 (+/- 15.42) percent of aortic pressures. Conclusion: Oral sildenafil is readily available and effective as an adjunctive agent in the treatment of post operative pulmonary hypertension.

Keywords: Pulmonary Hypertension, Sildenafil, Congenital Heart Disease, Ventricular Septal Defect, Patent Ductus Arteriosus.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )